Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirudh Prahallad

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Genetics & Development|April 8, 2019
Deciphering mechanisms of response and resistance in large-scale mouse cancer screensAnirudh Prahallad, Michael Rugaard Jensen, Emilie Anne Chapeau
Bioinformatics (Oxford, England)|June 23, 2018
Modelling signalling networks from perturbation dataMathurin Dorel, Bertram Klinger, Torsten Gross, et al.
Bioinformatics (Oxford, England)|November 14, 2018
Comparative Network Reconstruction using mixed integer programmingEvert Bosdriesz, Anirudh Prahallad, Bertram Klinger, et al.
Nature|January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRAnirudh Prahallad, Chong Sun, Sidong Huang, et al.
Blood|February 24, 2023
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysisGerard Socié, Dietger Niederwieser, Nikolas von Bubnoff, et al.
Experimental Hematology|October 3, 2022
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1<sup>low</sup> mouse modelPaola Verachi, Francesca Gobbo, Fabrizio Martelli, et al.
Computational and Structural Biotechnology Journal|February 27, 2020
Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft modelsKathleen Sprouffske, Grainne Kerr, Cheng Li, et al.
Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.
Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.
Blood|July 24, 2024
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Genetics & Development|April 8, 2019
Deciphering mechanisms of response and resistance in large-scale mouse cancer screensAnirudh Prahallad, Michael Rugaard Jensen, Emilie Anne Chapeau
Bioinformatics (Oxford, England)|June 23, 2018
Modelling signalling networks from perturbation dataMathurin Dorel, Bertram Klinger, Torsten Gross, et al.
Bioinformatics (Oxford, England)|November 14, 2018
Comparative Network Reconstruction using mixed integer programmingEvert Bosdriesz, Anirudh Prahallad, Bertram Klinger, et al.
Nature|January 28, 2012
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFRAnirudh Prahallad, Chong Sun, Sidong Huang, et al.
Blood|February 24, 2023
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysisGerard Socié, Dietger Niederwieser, Nikolas von Bubnoff, et al.
Experimental Hematology|October 3, 2022
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1<sup>low</sup> mouse modelPaola Verachi, Francesca Gobbo, Fabrizio Martelli, et al.
Computational and Structural Biotechnology Journal|February 27, 2020
Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft modelsKathleen Sprouffske, Grainne Kerr, Cheng Li, et al.
Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.
Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.
Blood|July 24, 2024
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 studyFranco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, et al.
Pageof 2